首页> 外文期刊>Journal of the American College of Surgeons >Positive predictive value of the AHRQ Patient Safety Indicator 'Postoperative Sepsis': implications for practice and policy.
【24h】

Positive predictive value of the AHRQ Patient Safety Indicator 'Postoperative Sepsis': implications for practice and policy.

机译:AHRQ患者安全指标“术后败血症”的积极预测价值:对实践和政策的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Patient Safety Indicator (PSI) 13, or "Postoperative Sepsis," of the Agency for Healthcare Quality and Research (AHRQ), was recently adopted as part of a composite measure of patient safety by the Centers for Medicare and Medicaid Services (CMS). We sought to examine its positive predictive value (PPV) by determining how well it identifies true cases of postoperative sepsis. STUDY DESIGN: Two retrospective cross-sectional studies of hospitalization records that met PSI 13 criteria were conducted, one within the Veterans Administration (VA) Hospitals from fiscal years (FY) 2003 to 2007, and one within community hospitals between October 1, 2005 and March 31, 2007. Trained abstractors reviewed medical records from each database using standardized abstraction instruments. We determined the PPV of the indicator and performed descriptive analyses of cases. RESULTS: Of 112 cases flagged and reviewed within the VA system, 59 were true events of postoperative sepsis, yielding a PPV of 53% (95% CI 42% to 64%). Within the community hospital sector, of 164 flagged and reviewed cases, 67 were true cases of postoperative sepsis, yielding a PPV of 41% (95% CI 28% to 54%). False positives were due to infections that were present on admission, urgent or emergent cases, no clinical diagnosis of sepsis, or other coding limitations such as nonspecific shock in postoperative patients. CONCLUSIONS: PSI 13 has relatively poor predictive ability to identify true cases of postoperative sepsis in both the VA and nonfederal sectors. The lack of information on diagnosis timing, confusion about the definition of elective admission, and coding limitations were the major reasons for false positives. As it currently stands, the use of PSI 13 as a stand-alone measure for hospital reporting appears premature.
机译:背景:医疗质量和研究机构(AHRQ)的患者安全指标(PSI)13或“术后脓毒症”最近被美国医疗保险和医疗补助中心(CMS)用作患者安全综合衡量指标的一部分。 )。我们试图通过确定其确定术后败血症的真实病例的方式来检查其阳性预测值(PPV)。研究设计:进行了两项符合PSI 13标准的住院记录回顾性横断面研究,一项在2003财政年度(FY)至2007财政年度在退伍军人管理局(VA)医院内进行,一项在2005年10月1日至2005年10月之间的社区医院内进行。 2007年3月31日。受过训练的抽象人员使用标准化的抽象工具审查了每个数据库中的病历。我们确定了指标的PPV,并对案例进行了描述性分析。结果:在VA系统内标记并复查的112例病例中,有59例是术后败血症的真实事件,PPV为53%(95%CI 42%至64%)。在社区医院部门中,有164个标记并复查的病例中,有67个是真正的术后败血症病例,PPV为41%(95%CI 28%至54%)。假阳性是由于入院时出现感染,紧急或紧急情况,没有败血症的临床诊断或其他编码限制(如术后患者的非特异性休克)引起的。结论:PSI 13预测VA和非联邦部门术后败血症的真实病例的预测能力相对较差。缺乏有关诊断时机的信息,对择期入学定义的混淆以及编码限制是造成假阳性的主要原因。按照目前的情况,使用PSI 13作为医院报告的独立措施似乎为时过早。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号